Alector, Inc. (ALEC) shareholders
Close on Nov 17, 2026Market cap $285.84MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| David Kroin Joint filing with Deep Track Capital, LP (8.61%), Deep Track Biotechnology Master Fund, Ltd. (8.61%) | 12,772,152 | 8.61% | 13G (passive) | Oct 16, 2026 |
| Chen Yu | 10,000,000 | 9.20% | 13G (passive) | Oct 22, 2025 |
| Lampert Mark N Joint filing with Bvf Partners L P/Il (8.40%), Bvf Inc/Il (8.40%) and 1 more | 9,374,267 | 8.40% | 13G (passive) | Sep 11, 2026 |
| Arnon Rosenthal | 8,213,925 | 7.40% | 13G (passive) amendment | Dec 31, 2025 |
| RA Capital Healthcare Fund, L.P. Joint filing with RA Capital Management, L.P. (5.10%), Peter Kolchinsky (5.10%) and 1 more | 7,500,000 | 5.10% | 13G (passive) | Oct 19, 2026 |
| BlackRock, Inc. | 5,784,214 | 5.20% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ALEC | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| TCG Crossover Management, LLC | 10,000,000 | 8.96% | $20.10M | – | 0.48% |
| Nantahala Capital Management, LLC | 8,636,218 | 7.73% | $17.36M | +5,820,235 | 0.29% |
| BlackRock, Inc. | 7,847,879 | 7.03% | $15.77M | +106,634 | 0.00% |
| Acadian Asset Management LLC | 4,414,345 | 3.95% | $8.86M | +375,560 | 0.01% |
| Vanguard Capital Management LLC | 4,009,340 | 3.59% | $8.06M | +330,618 | 0.00% |
| Kynam Capital Management, LP | 3,808,494 | 3.41% | $7.66M | +1,808,494 | 0.42% |
| Merck & Co., Inc. | 3,545,719 | 3.18% | $7.13M | – | 1.35% |
| Balyasny Asset Management L.P. | 3,247,426 | 2.91% | $6.53M | +312,173 | 0.01% |
| 683 Capital Management, LLC | 3,200,000 | 2.87% | $6.43M | – | 0.32% |
| D. E. Shaw & Co., Inc. | 2,959,983 | 2.65% | $5.95M | −372,852 | 0.00% |
| ADAR1 Capital Management, LLC | 2,883,583 | 2.58% | $5.80M | +1,833,583 | 0.27% |
| Vanguard Portfolio Management LLC | 2,820,493 | 2.53% | $5.67M | +236,951 | 0.00% |
| Geode Capital Management, LLC | 2,454,271 | 2.20% | $4.93M | +168,053 | 0.00% |
| Spruce Street Capital LP | 2,101,068 | 1.88% | $4.22M | – | 0.83% |
| Millennium Management LLC | 1,988,835 | 1.78% | $4.00M | +9,609 | 0.00% |
| Ikarian Capital, LLC | 1,982,606 | 1.78% | $3.99M | −100,000 | 0.43% |
| State Street Corp | 1,879,765 | 1.68% | $3.78M | +14,239 | 0.00% |
| Jacobs Levy Equity Management, Inc | 1,765,929 | 1.58% | $3.55M | −388,432 | 0.01% |
| Medici Capital LLC | 1,652,520 | 1.48% | $3.32M | – | 6.51% |
| Affinity Asset Advisors, LLC | 1,510,000 | 1.35% | $3.04M | +1,010,000 | 0.14% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 141 | 96M | 85.8% | 14 / 59 | 35 / 9 | 15M | 8M |
| Q1 2026 | 138 | 88M | 79.2% | 29 / 43 | 37 / 20 | 17M | 6M |
| Q4 2025 | 131 | 85M | 75.7% | 25 / 41 | 40 / 39 | 38M | 28M |
| Q3 2025 | 149 | 75M | 67.1% | 25 / 45 | 41 / 12 | 14M | 10M |
| Q2 2025 | 136 | 71M | 63.5% | 17 / 47 | 38 / 22 | 13M | 15M |
| Q1 2025 | 141 | 73M | 65.1% | 20 / 46 | 33 / 28 | 4M | 5M |
| Q4 2024 | 150 | 73M | 65.8% | 31 / 46 | 38 / 39 | 20M | 22M |
| Q3 2024 | 159 | 75M | 67.4% | 20 / 48 | 50 / 19 | 16M | 6M |
| Q2 2024 | 160 | 74M | 66.7% | 24 / 58 | 50 / 19 | 8M | 16M |
| Q1 2024 | 157 | 83M | 73.9% | 28 / 61 | 35 / 17 | 15M | 3M |
| Q4 2023 | 148 | 70M | 63.1% | 16 / 49 | 49 / 15 | 13M | 6M |
| Q3 2023 | 148 | 63M | 56.7% | 20 / 59 | 40 / 17 | 11M | 6M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
129 funds held ALEC in Q2 2026, 53% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of ALEC | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2,837,922 | 2.54% | $5.70M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 2,548,224 | 2.28% | $5.12M | 0.01% | Jun 30, 2026 |
| Select Biotechnology Portfolio | 1,380,204 | 1.24% | $2.98M | 0.06% | May 31, 2026 |
| Fidelity Small Cap Index Fund | 1,067,159 | 0.96% | $1.61M | 0.00% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 1,033,776 | 0.93% | $2.08M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF | 820,921 | 0.74% | $1.65M | 0.01% | Jun 30, 2026 |
| Vanguard Explorer Fund | 673,493 | 0.60% | $1.02M | 0.00% | Jul 31, 2026 |
| BlackRock Advantage Small Cap Core Fund | 635,411 | 0.57% | $1.37M | 0.03% | May 29, 2026 |
| Vanguard Strategic Small-Cap Equity Fund | 628,627 | 0.56% | $1.26M | 0.04% | Jun 30, 2026 |
| Small Company Growth Portfolio | 615,923 | 0.55% | $1.24M | 0.07% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 484,110 | 0.43% | $1.05M | 0.00% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 468,899 | 0.42% | $1.01M | 0.01% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 441,696 | 0.40% | $954.06K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 330,159 | 0.30% | $663.62K | 0.04% | Jun 30, 2026 |
| Schwab Small-Cap Index Fund | 239,291 | 0.21% | $361.33K | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Arnon Rosenthal | Chief Executive Officer, Director | 3,514,600 | 3.15% | Oct 15, 2026 |
| Grace Wong-Sarad | Principal Accounting Officer | 161,570 | 0.14% | Oct 15, 2026 |
| Neil Lindsay Berkley | CFO & Chief Business Officer | 395,216 | 0.35% | Oct 15, 2026 |
| Sara Kenkare-Mitra | President and Head of R&D | 501,652 | 0.45% | Dec 3, 2025 |
| Marc Grasso | Chief Financial Officer | 296,072 | 0.27% | Jun 4, 2025 |
| Gary Romano | Chief Medical Officer | 332,977 | 0.30% | Mar 5, 2025 |
| Elizabeth A. Garofalo | Director | 118,650 | 0.11% | Jun 17, 2026 |
| Mark Altmeyer | Director | 98,650 | 0.09% | Jun 17, 2026 |
| Errol B. Desouza | Director | 98,650 | 0.09% | Jun 17, 2026 |
| Louis J. Lavigne Jr | Director | 138,661 | 0.12% | Jun 17, 2026 |
| Richard H. Scheller | Director | 134,899 | 0.12% | Jun 17, 2026 |
| Kristine Yaffe | Director | 124,109 | 0.11% | Jun 17, 2026 |
| Paula Hammond | Director | 103,609 | 0.09% | Jun 17, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Arnon Rosenthal Chief Executive Officer, Director | Oct 14, 2026 | Award | +217,500 | – | – | 2,512,100 |
| Neil Lindsay Berkley CFO & Chief Business Officer | Oct 14, 2026 | Award | +44,567 | – | – | 395,216 |
| Grace Wong-Sarad Principal Accounting Officer | Oct 14, 2026 | Award | +55,555 | – | – | 161,570 |
| Grace Wong-Sarad Principal Accounting Officer | Sep 4, 2026 | Sale(10b5-1 plan) | −3,625 | $2.51 | $9.10K | 106,015 |
| Grace Wong-Sarad Principal Accounting Officer | Sep 3, 2026 | Sale(10b5-1 plan) | −5,165 | $2.67 | $13.79K | 109,640 |
| Neil Lindsay Berkley CFO & Chief Business Officer | Sep 3, 2026 | Sale | −29,251 | $2.66 | $77.81K | 350,649 |
| Arnon Rosenthal Chief Executive Officer, Director | Sep 3, 2026 | Sale | −72,606 | $2.66 | $193.13K | 2,294,600 |
| Grace Wong-Sarad Principal Accounting Officer | Sep 2, 2026 | Sale(10b5-1 plan) | −656 | $2.75 | $1.80K | 114,805 |
| Arnon Rosenthal Chief Executive Officer, Director | Aug 19, 2026 | Gift | +350,000 | – | – | 1,002,500 |
| Arnon Rosenthal Chief Executive Officer, Director | Aug 19, 2026 | Gift | +350,000 | – | – | 1,002,500 |
| Arnon Rosenthal Chief Executive Officer, Director | Aug 19, 2026 | Gift | −1,050,000 | – | – | 922,875 |
| Arnon Rosenthal Chief Executive Officer, Director | Aug 19, 2026 | Gift | +350,000 | – | – | 1,002,500 |
| Grace Wong-Sarad Principal Accounting Officer | Jul 9, 2026 | Award | +20,000 | – | – | 115,461 |
| Mark Altmeyer Director | Jun 17, 2026 | Award | +28,700 | – | – | 98,650 |
| Elizabeth A. Garofalo Director | Jun 17, 2026 | Award | +28,700 | – | – | 118,650 |
| Errol B. Desouza Director | Jun 17, 2026 | Award | +28,700 | – | – | 98,650 |
| Kristine Yaffe Director | Jun 17, 2026 | Award | +28,700 | – | – | 124,109 |
| Richard H. Scheller Director | Jun 17, 2026 | Award | +28,700 | – | – | 134,899 |
| Paula Hammond Director | Jun 17, 2026 | Award | +28,700 | – | – | 103,609 |
| Louis J. Lavigne Jr Director | Jun 17, 2026 | Award | +28,700 | – | – | 128,109 |
| Grace Wong-Sarad Principal Accounting Officer | Jun 3, 2026 | Sale(10b5-1 plan) | −3,475 | $1.88 | $6.53K | 95,461 |
| Arnon Rosenthal Chief Executive Officer, Director | Jun 2, 2026 | Sale | −87,216 | $1.97 | $171.82K | 2,367,206 |
| Neil Lindsay Berkley CFO & Chief Business Officer | Jun 2, 2026 | Sale | −19,360 | $1.97 | $38.14K | 379,900 |
| Grace Wong-Sarad Principal Accounting Officer | Jun 2, 2026 | Sale(10b5-1 plan) | −5,709 | $1.97 | $11.25K | 98,936 |
| Richard H. Scheller Director | Jun 1, 2026 | Award | +10,833 | – | – | 106,199 |
| Grace Wong-Sarad Principal Accounting Officer | Apr 16, 2026 | Sale(10b5-1 plan) | −1,820 | $2.65 | $4.82K | 104,645 |
| Neil Lindsay Berkley CFO & Chief Business Officer | Mar 15, 2026 | Award | +54,600 | – | – | 399,260 |
| Arnon Rosenthal Chief Executive Officer, Director | Mar 13, 2026 | Award | +116,246 | – | – | 2,454,422 |
| Grace Wong-Sarad Principal Accounting Officer | Mar 10, 2026 | Sale(10b5-1 plan) | −1,000 | $2.65 | $2.65K | 106,465 |
| Grace Wong-Sarad Principal Accounting Officer | Mar 3, 2026 | Sale(10b5-1 plan) | −3,367 | $2.08 | $7.00K | 107,465 |
| Arnon Rosenthal Chief Executive Officer, Director | Mar 2, 2026 | Sale | −81,864 | $2.12 | $173.55K | 2,338,176 |
| Grace Wong-Sarad Principal Accounting Officer | Mar 2, 2026 | Sale | −8,071 | $2.12 | $17.11K | 110,832 |
| Neil Lindsay Berkley CFO & Chief Business Officer | Mar 2, 2026 | Sale | −29,649 | $2.12 | $62.86K | 344,660 |
| Grace Wong-Sarad Principal Accounting Officer | Feb 26, 2026 | Sale(10b5-1 plan) | −4,079 | $2.50 | $10.20K | 118,903 |
| Grace Wong-Sarad Principal Accounting Officer | Dec 5, 2025 | Sale(10b5-1 plan) | −4,753 | $1.21 | $5.75K | 122,982 |
| Sara Kenkare-Mitra President and Head of R&D | Dec 3, 2025 | Sale | −41,687 | $1.12 | $46.69K | 501,652 |
| Grace Wong-Sarad Principal Accounting Officer | Dec 3, 2025 | Sale | −8,056 | $1.12 | $9.02K | 127,735 |
| Neil Lindsay Berkley Chief Bus Ofcr & Interim CFO | Dec 3, 2025 | Sale | −37,261 | $1.12 | $41.73K | 374,309 |
| Arnon Rosenthal Chief Executive Officer, Director | Dec 3, 2025 | Sale | −104,347 | $1.12 | $116.87K | 2,420,040 |
| Grace Wong-Sarad Principal Accounting Officer | Nov 10, 2025 | Award | +32,343 | – | – | 135,791 |
| Neil Lindsay Berkley Chief Bus Ofcr & Interim CFO | Nov 10, 2025 | Award | +65,000 | – | – | 411,570 |
| Arnon Rosenthal Chief Executive Officer, Director | Nov 10, 2025 | Award | +174,167 | – | – | 2,524,387 |
| Grace Wong-Sarad Principal Accounting Officer | Sep 2, 2025 | Sale | −5,910 | $2.50 | $14.78K | 103,448 |
| Sara Kenkare-Mitra President and Head of R&D | Sep 2, 2025 | Sale | −23,638 | $2.50 | $59.10K | 543,339 |
| Arnon Rosenthal Chief Executive Officer, Director | Sep 2, 2025 | Sale | −51,562 | $2.50 | $128.91K | 2,350,220 |
| Neil Lindsay Berkley Principal Financial Officer | Sep 2, 2025 | Sale | −15,842 | $2.50 | $39.61K | 346,570 |
| Paula Hammond Director | Aug 26, 2025 | Sale(10b5-1 plan) | −14,000 | $2.36 | $33.04K | 74,909 |
| Sara Kenkare-Mitra President and Head of R&D | Jul 1, 2025 | Award | +54,725 | – | – | 566,977 |
| Arnon Rosenthal Chief Executive Officer, Director | Jul 1, 2025 | Award | +137,125 | – | – | 2,551,782 |
| Kristine Yaffe Director | Jun 20, 2025 | Sale(10b5-1 plan) | −1,000 | $1.44 | $1.44K | 95,409 |
| Paula Hammond Director | Jun 11, 2025 | Award | +28,700 | – | – | 88,909 |
| Elizabeth A. Garofalo Director | Jun 11, 2025 | Award | +28,700 | – | – | 89,950 |
| Errol B. Desouza Director | Jun 11, 2025 | Award | +28,700 | – | – | 69,950 |
| Kristine Yaffe Director | Jun 11, 2025 | Award | +28,700 | – | – | 96,409 |
| Mark Altmeyer Director | Jun 11, 2025 | Award | +28,700 | – | – | 69,950 |
| Louis J. Lavigne Jr Director | Jun 11, 2025 | Award | +28,700 | – | – | 99,409 |
| Richard H. Scheller Director | Jun 11, 2025 | Award | +28,700 | – | – | 95,366 |
| Sara Kenkare-Mitra President and Head of R&D | Jun 2, 2025 | Sale | −23,890 | $1.34 | $32.01K | 512,252 |
| Arnon Rosenthal Chief Executive Officer, Director | Jun 2, 2025 | Sale | −52,087 | $1.34 | $69.80K | 2,414,657 |
| Marc Grasso Chief Financial Officer | Jun 2, 2025 | Sale | −16,488 | $1.34 | $22.09K | 296,072 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Alector's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,680,065 shares on Oct 6, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Grace Wong-Sarad Officer | Sep 4, 2026 | 3,625 | $9.09K | Sep 4, 2026 | Restricted Stock |
| Grace Wong-Sarad Officer | Sep 2, 2026 | 656 | $1.80K | Sep 2, 2026 | Restricted Stock |
| Grace Wong-Sarad Officer | Sep 1, 2026 | 5,662 | $13.59K | Sep 2, 2026 | Vesting of Restricted Stock Units |
| Arnon Rosenthal Officer, Director | Sep 1, 2026 | 79,702 | $191.28K | Sep 2, 2026 | Vesting of Restricted Stock Units |
| Neil Lindsay Berkley Officer | Sep 1, 2026 | 32,103 | $77.05K | Sep 2, 2026 | Vesting of Restricted Stock Units |
| Grace Wong-Sarad Officer | Jun 3, 2026 | 3,475 | $6.54K | Jun 3, 2026 | Restricted Stock |
| Neil Lindsay Berkley Officer | Jun 1, 2026 | 18,213 | $37.70K | Jun 2, 2026 | Vesting of Restricted Stock Units |
| Grace Wong-Sarad Officer | Jun 1, 2026 | 5,239 | $10.84K | Jun 2, 2026 | Vesting of Restricted Stock Units |
| Arnon Rosenthal Officer, Director | Jun 1, 2026 | 67,572 | $139.87K | Jun 2, 2026 | Vesting of Restricted Stock Units |
| Grace Wong-Sarad Officer | Apr 16, 2026 | 1,820 | $4.82K | Apr 16, 2026 | Restricted Stock |
| Grace Wong-Sarad Officer | Mar 10, 2026 | 1,000 | $2.65K | Mar 10, 2026 | Restricted Stock |
| Grace Wong-Sarad Officer | Mar 3, 2026 | 3,367 | $7.01K | Mar 3, 2026 | Restricted Stock |
| Neil Lindsay Berkley Officer | Feb 27, 2026 | 23,161 | $56.28K | Mar 2, 2026 | Vesting of Restricted Stock Units |
| Arnon Rosenthal Officer, Director | Feb 27, 2026 | 67,571 | $164.20K | Mar 2, 2026 | Vesting of Restricted Stock Units |
| Grace Wong-Sarad Officer | Feb 27, 2026 | 6,297 | $15.30K | Mar 2, 2026 | Vesting of Restricted Stock Units |
See a number that looks wrong?